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Uterine leiomyomas are benign smooth muscle 
tumours of the uterus and the commonest benign 
tumours seen in women during the reproductive age. 
1,2,3
 It is more common among women of African 
descent and are oestrogen and progesterone 
dependent tumours, thus they regress significantly 
2,3,4.
after menopause.  They are therefore usually rare 
2,3,4,5
and asymptomatic after menopause. 
Therefore, presentation with huge uterine 
leiomyoma with postmenopausal bleeding and 
weight loss requires a critical evaluation and urgent 
management.
This paper reports a rare case of huge uterine 
leiomyoma, with postmenopausal bleeding and 
weight loss in a 5 year post-menopausal woman. She 
had Exploratory Laparotomy and Bilateral Salpingo- 
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We report a case of huge symptomatic uterine leiomyoma in an obese 58 year old, P4 , 5 years 
postmenopausal woman. She presented with progressive abdominal swelling, weight loss and 
postmenopausal bleeding. These made us suspect intra-abdominal malignancy, however investigations 
showed features of benign tumour. She had exploratory laparotomy, total abdominal hysterectomy and 
bilateral salpingo-oophorectomy. Findings at surgery were consistent with benign abdominopelvic mass. 
Histological investigation,  showed uterine leiomyoma. 
Huge symptomatic uterine leiomyoma is a rare occurence after menopause. It size at presentation also made 
definitive diagnosis a dilemma because of the possibility of intra-abdominal malignancy.





This 58 year old P4  , 5 year postmenopausal widow, 
presented with 6 year history of abdominal swelling, 
a year history of weight loss, urinary frequency and 
urgency, and the passage of serosanguinous fluid  per 
vaginam.
She had regular menstruation until 5 years prior to 
presentation. She had 4 vaginal deliveries between 
1980 and 1989. She attained menarche at the age of 
109
Trop J Obstet Gynaecol, 33 (1), April 2016
assessment. 
She consented to Exploratory laparotomy, total 
abdominal hysterectomy and bilateral salpingo-
oophorectomy under general anesthesia using a 
midline abdominal incision. The findings at surgery 
were: huge uterus with multiple leiomyomas; 
submucous, subserous and intramural and weighed 
4.8 kg. Pedunculated fundal leiomyoma measuring 
14×12cm, atrophic ovaries bilaterally, dilated 
tortuous blood vessels on the uterus, mostly on the 
leiomyomas. There were no peritoneal seedlings and 
no ascites. The liver, the kidneys, the bladder and the 
guts were grossly normal (See the figure below). The 
estimated blood loss was 750 ml.
She had intra-operative intravenous Ceftriaxone 1g 
and Metronidazole 500mg. These were continued 
until 48 hours after surgery. Her post-operation 
packed cell volume was 23% on the second post-
operative day. She was transfused with 2 pints of 
blood and the post-transfusion packed cell volume 
was 27%. The post-operative condition was 
uneventful. She was discharged home by the fourth 
post-operation day on oral antibiotics, analgesic and 
haematinics excluding folic acid.
Her clinical condition was satisfactory at the follow-
up Clinic visits (2 and 6 weeks after surgery), her 
packed cell volume was 30% and the histology report 
revealed multiple uterine leiomyomata with no 
evidence of malignancy. The details of the surgery 
and the histology reports were explained to her
DISCUSSION
Uterine leiomyomata are benign smooth muscle 
tumours of the uterus, found commonly in women of 
the reproductive age and predominantly in women of 
1,2,3African descent.  Uterine leiomyomata regress 
2,3,4,7after menopause.  It constitutes about 20-30% of 
the gynaecological cases managed in most tertiary 
health care facilities. The incidence and the clinical 
manifestations increase with the age of the women 
14 years and used combined oral contraceptive pills 
for 6 years after her last delivery, but she was not 
sexually active at the time of presentation. She was a 
known hypertensive diagnosed 2 years before 
presentation and had been on Tab Amlodopine 10mg 
daily and Tab Aldomet 500mg twice daily with good 
compliance. She had no history of previous surgical 
operation. 
On examination, she was obese, mildly pale, afebrile 
and anicteric.  There was no peripheral  
lymphadenopathy. Her body weight and height were 
110kg and 1.61metres respectively, giving a body 
m2
mass index of 42.44kg/ . Her blood pressure was 
140/100mmHg and only the first and the second 
heart sounds were heard on auscultation.
Abdomino-pelvic ultrasonography showed multiple 
calcified uterine myoma. We made a provisional 
diagnosis of huge Uterine leiomyoma in a post-
menopausal woman to rule out uterine malignancy. 
In view of her age and the above symptoms, the 
following investigations were carried out to make a 
definitive diagnosis and to prepare her for 
Exploratory laparotomy. Her packed cell volume 
9
was 32%, total white blood cell count was 5.0×10  
/liter, retroviral screening was negative, her liver 
function tests, electrolytes, urea and creatinine, 
fasting blood sugar and 2 hours post-prandial 
glucose were normal. Her platelet count was 
3
263,000/mm . The Electrocardiography (ECG) 
showed sinus tachycardia and was reviewed by a 
cardiologist. Her Computerized Tomography scan  
(CT scan) of the abdomen and the pelvis showed 
symptomatic massive pedunculated uterine 
leiomyoma to rule out leiomyosarcoma. Endometrial 
biopsy and cervical tissue were sent for 
histopathological assessment. The findings were: 
normal ectocervical tissues, the endocervical cells 
revealed atypical squamous cells of undetermined 
significance (ASCUS), but the endometrial biopsy 
was said to be insufficient for histopathological 
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ultrasonography and/or magnetic resonance imaging 
(MRI) are invaluable tools to make a definitive 
diagnosis. Unfortunately these imaging techniques 
can not clearly distinguish between benign and 
malignant leiomyoma (leiomyosarcoma), although 
malignant transformation is rare with an incidence of 
3,80.1-0.6%.   However, rapid growth, unexpected 
growth such as huge leiomyoma after menopause or 
peripheral lymphadenopathy may raise suspicion of 
malignant transformation. This was a big challenge 
in this case, with abdominal pelvic mass of 36 weeks 
size and weight loss after menopause. We therefore 
requested for computerized tomography scan (CT 
scan) of the abdomen and the pelvis, endometrial 
biopsy and Pap smear.
Degenerative changes result, when uterine 
leiomyoma has outgrown their blood supply. The 
commonest degenerative change is hyaline 
7,17degeneration.  Others are; calcification, cystic, 
fatty changes myxomatous changes and red 
degeneration which occurs  during pregnancy. 
Calcification is common after menopause. In this 
case the abdomino-pelvic ultrasonography and the 
CT scan of the abdomen and the pelvis showed 
features of cystic and calcific changes.
Most cases of uterine leiomyoma does not require 
treatment when they are asymptomatic, either during 
the reproductive age or after menopause. However in 
those symptomatic cases, management involves 
medication to control symptoms or to shrink the 
tumours,  surgical  interventions such as 
myomectomy, abdominal or laparoscopic 
hysterectomy depending on the age, and the parity of 
2 , 3 , 4the patients.  Other minimally invasive 
radiological or surgical interventions includes, 
uterine artery embolization, bilateral uterine artery 
3,4,19ligation and radio frequency ablation.   In this 
+0case, the patient was P4 , 5 years post-menopausal 
woman, with huge symptomatic uterine leiomyoma 
and there was no feature of disseminated malignancy. 
 7,8,9
and reduced with increased parity.  The  wide 
disparity of the incidence is due to the fact that many 
of the women are asymptomatic, have poor 
knowledge or misconception about the disease and 
so do not present in the hospital for the appropriate 
 10
and timely management .
The exact cause of uterine leiomyoma is not clearly 
understood, but some associated risk factors include; 
racial especially african–american origin, obesity, 
family history especially first degree relatives, 
nulliparity and reproductive age because they are 
oestrogen and progesterone dependent for their 
11,12,13 +0
growth.   In this case, the patient was P4 , 
morbidly obese with body mass index (BMI) of 
2
42.44kg/m  and had a uterine mass that weighed 
4.8kg. She was a post-menopausal woman with no 
family history of uterine leiomyoma. Interestingly, 
some authors have reported cases of leiomyoma in 
7,14,15,16,17
post-menopausal women.  The authors 
suggested different mechanisms other than 
oestrogen and progesterone during the reproductive 
age. These includes; the stimulation effects of 
insulin-like growth factors (IGF), epidermal growth 
factors (EGF), polypeptides growth factors such as 
platelet derived growth factors (PDGF), 
transforming growth factors, granulocyte-
macrophage colony-stimulating factors and vascular 
endothelial growth factors (VEGF). Similarly in the 
obese post-menopausal women, peripheral 
conversion of androstenedione derived from the 
adrenal glands to oestrone by aromatization of fat has 
been suggested for the stimulation of growth of 
16,17
leiomyomas in this group of women.  Thus our 
reported case might have received stimulation from 
the growth factors and the aromatization of the 
peripheral fat to oestrone because of her morbid 
2
obesity (BMI: 42.44kg/m ). These, possibly was 
responsible for the huge size of the leiomyoma.
Detailed history, astitute clinical examination and 
radiological investigations such as abdomino-pelvic 
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We therefore counseled her for total abdominal 
hysterectomy and bilateral salpingo-oophorectomy, 
to prevent future malignant transformation, since the 
ovaries were not expected to be functional after 
menopause
CONCLUSION
Uterine leiomyomas are rare after menopause and are 
usually asymptomatic, because they are expected to 
shrink after menopause. This reported case, showed 
that uterine leiomyomas can be huge in size and 
symptomatic after menopause without malignant 
transformation. However, the presentation with post-
menopausal bleeding as seen in this patient requires 
adequate investigations to exclude disseminated 
gynaecological or intra-abdominal malignancy 
before embarking on surgical intervention.
FIGURE 1:HUGE UTERINE MASS AND ITS TUBES WITH PERITONEAL ADHESIONS
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